GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sastasundar Ventures Ltd (NSE:SASTASUNDR) » Definitions » EBIT

Sastasundar Ventures (NSE:SASTASUNDR) EBIT : ₹567 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sastasundar Ventures EBIT?

Sastasundar Ventures's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ₹53 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹567 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sastasundar Ventures's annualized ROC % for the quarter that ended in Mar. 2024 was -218.98%. Sastasundar Ventures's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 29.38%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sastasundar Ventures's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 21.38%.


Sastasundar Ventures EBIT Historical Data

The historical data trend for Sastasundar Ventures's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sastasundar Ventures EBIT Chart

Sastasundar Ventures Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -567.95 -154.31 11,111.04 -364.85 566.88

Sastasundar Ventures Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.37 192.77 108.79 212.45 52.86

Competitive Comparison of Sastasundar Ventures's EBIT

For the Pharmaceutical Retailers subindustry, Sastasundar Ventures's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sastasundar Ventures's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sastasundar Ventures's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sastasundar Ventures's EV-to-EBIT falls into.



Sastasundar Ventures EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹567 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sastasundar Ventures  (NSE:SASTASUNDR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sastasundar Ventures's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-914.616 * ( 1 - -583.03% )/( (0 + 2852.868)/ 1 )
=-6247.1016648/2852.868
=-218.98 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=11495.93 - 425.379 - ( 8354.155 - max(0, 646.096 - 8863.779+8354.155))
=2852.868

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Sastasundar Ventures's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=211.436/( ( (0 + max(0, 0)) + (719.554 + max(-180.816, 0)) )/ 1 )
=211.436/( ( 0 + 719.554 )/ 1 )
=211.436/719.554
=29.38 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(426.452 + 0 + 0) - (425.379 + 0 + 181.889)
=-180.816

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sastasundar Ventures's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=566.88/2651.343
=21.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sastasundar Ventures EBIT Related Terms

Thank you for viewing the detailed overview of Sastasundar Ventures's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sastasundar Ventures (NSE:SASTASUNDR) Business Description

Traded in Other Exchanges
Address
7 Abanindra Nath Thakur Sarani, Azimganj House, 2nd Floor, Kolkata, WB, IND, 700017
Sastasundar Ventures Ltd is a Core Investment Company. It is engaged in the business of healthcare services through its subsidiary companies. Its service verticals are Pharmacy, Diagnostics and Wellness. The group primarily operates in India.

Sastasundar Ventures (NSE:SASTASUNDR) Headlines

No Headlines